Long-term effects of natalizumab on MRI activity and clinical outcomes in Japanese patients with relapsing-remitting multiple sclerosis

BACKGROUND: Relapsing-remitting multiple sclerosis (RRMS) is the most common phenotype of multiple sclerosis (MS), and its active stage is characterized by active T2 lesions with or without gadolinium (Gd) enhancement on magnetic resonance imaging (MRI). Natalizumab is indicated as monotherapy in ad...

Descripción completa

Detalles Bibliográficos
Autores principales: Saida, Takahiko, Hao, Qi, Kanda, Michihiro, Tani, Yumiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10463665/
https://www.ncbi.nlm.nih.gov/pubmed/37644415
http://dx.doi.org/10.1186/s12883-023-03297-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10463665/
https://www.ncbi.nlm.nih.gov/pubmed/37644415
http://dx.doi.org/10.1186/s12883-023-03297-1

Ejemplares similares